Literature DB >> 29935601

Severe bradycardia and asystole after sugammadex.

S S Bhavani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29935601     DOI： 10.1016/j.bja.2018.02.036

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  10 in total

1.  Heart rate changes following the administration of sugammadex in children: a prospective, observational study.

Authors:  Mohammad Alsuhebani; Trent Sims; Jennifer K Hansen; Mohammed Hakim; Hina Walia; Rebecca Miller; Dmitry Tumin; Joseph D Tobias
Journal:  J Anesth       Date:  2020-01-24       Impact factor: 2.078

2.  Heart Rate Changes Following the Administration of Sugammadex to Infants and Children With Comorbid Cardiac, Cardiovascular, and Congenital Heart Diseases.

Authors:  Jordan Arends; Richard Hubbard; Shabana Z Shafy; Mohammed Hakim; Stephani S Kim; Dmitry Tumin; Joseph D Tobias
Journal:  Cardiol Res       Date:  2020-08-01

3.  Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study.

Authors:  Ákos I Fábián; Edömér Tassonyi; Vera Csernoch; Marianna Fedor; Tamás Sohajda; Lajos Szente; Béla Fülesdi
Journal:  BMC Anesthesiol       Date:  2021-08-17       Impact factor: 2.217

Review 4.  Sugammadex induced bradycardia and hypotension: A case report and literature review.

Authors:  I-Chia Teng; Ying-Jen Chang; Yao-Tsung Lin; Chin-Chen Chu; Jen-Yin Chen; Zhi-Fu Wu
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

5.  Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.

Authors:  Carmen Fierro; Alessandro Medoro; Donatella Mignogna; Carola Porcile; Silvia Ciampi; Emanuele Foderà; Romeo Flocco; Claudio Russo; Gennaro Martucci
Journal:  Medicina (Kaunas)       Date:  2021-01-19       Impact factor: 2.430

6.  Cardiovascular adverse effects of sugammadex.

Authors:  Mukul Chandra Kapoor
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2020-09-29

7.  A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participants.

Authors:  David M Broussard; Manfred Blobner; W Joseph Herring; Yuki Mukai; Aobo Wang; Jeannine Lutkiewicz; John F Lombard; Li Lin; Molly Watkins
Journal:  BMC Anesthesiol       Date:  2021-10-28       Impact factor: 2.217

8.  Adverse events of sugammadex that occurred in a Korean population.

Authors:  Woong Han; Jong Min Lee; Dong Ho Park; Chia An Lee; Chang Yeong Jeong; Hong Seuk Yang
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-05

9.  Evaluation of the Toxicity of Sugammadex in Zebrafish Larvae.

Authors:  Woon Young Kim; Yeon Hwa Kim; Ji Yoon Lee; Jae Hwan Kim; Too Jae Min
Journal:  J Korean Med Sci       Date:  2020-03-09       Impact factor: 2.153

10.  Should we Routinely Reverse Neuromuscular Blockade with Sugammadex in Patients with a History of Heart Transplantation?

Authors:  Koichi Yuki; Rebecca Scholl
Journal:  Transl Perioper Pain Med       Date:  2020-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.